Investor profile
Janus Henderson Investors has backed 3 European tech companies across 3 funding rounds between 2018 and 2025, joining rounds totalling €243M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| Artios | UK | 1 | €99M |
| Aprea Therapeutics | Sweden | 1 | €5.0M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Artios | Series D+ | €99M | 2025-11 |
| Aprea Therapeutics | Series C | €5.0M | 2019-01 |
